Epigenetic alterations in patients with type 2 diabetes mellitus

The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females

(2014) Nisreen Al-Moghrabi et al.   BMC CANCER

Genetic Screening for the Risk of Type 2 Diabetes: Worthless or valuable?

(2013) V. Lyssenko et al.   DIABETES CARE

Scavenger receptor class A member 3 (SCARA3) in disease progression and therapy resistance in multiple myeloma

(2013) Charles O. Brown et al.   LEUKEMIA RESEARCH

Epigenetics and diabetes treatment: an unrealized promise?

(2012) Nuria C. Bramswig et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Cancer epigenetics: linking basic biology to clinical medicine

(2011) Hsing-Chen Tsai et al.   CELL RESEARCH

Peroxiredoxin 2 Deficiency Exacerbates Atherosclerosis in Apolipoprotein E–Deficient Mice

(2011) Jong-Gil Park et al.   CIRCULATION RESEARCH

Genetic etiology of type 2 diabetes mellitus: a review

(2011) Uma Jyothi Kommoju et al.   International Journal of Diabetes in Developing Countries

Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma

(2010) B. A. Walker et al.   BLOOD

Molecular marks for epigenetic identification of developmental and cancer stem cells

(2010) Samir Kumar Patra et al.   Clinical Epigenetics

Epigenetics: A Molecular Link Between Environmental Factors and Type 2 Diabetes

(2009) Charlotte Ling et al.   DIABETES

An operational definition of epigenetics

(2009) S. L. Berger et al.   GENES & DEVELOPMENT

Methyl-CpG binding proteins: specialized transcriptional repressors or structural components of chromatin?

(2008) T. Clouaire et al.   CELLULAR AND MOLECULAR LIFE SCIENCES